Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
78°
Cloudy
Site search
Search
Menu
Subscribe
Home
News
Local News
Sports
Obituaries
Photos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Explore the Sheyenne
Best of 2023
Archives
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Decibel Therapeutics Inc
(NQ:
DBTX
)
N/A
UNCHANGED
Last Price
Updated: 4:00 PM EDT, Sep 22, 2023
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Decibel Therapeutics Inc
< Previous
1
2
3
Next >
DECIBEL THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Decibel Therapeutics, Inc. - DBTX
September 05, 2023
From
Kahn Swick & Foti, LLC
Via
Business Wire
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Acer Therapeutics Inc. (Nasdaq - ACER), Sovos Brands, Inc. (Nasdaq - SOVO), Computer Task Group, Incorporated (Nasdaq - CTG), Decibel Therapeutics, Inc. (Nasdaq -
August 31, 2023
From
Brodsky & Smith LLC
Via
GlobeNewswire
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Sovos Brands, Inc. (Nasdaq - SOVO), Zynerba Pharmaceuticals, Inc. (Nasdaq - ZYNE), Computer Task Group, Incorporated (Nasdaq - CTG), Decibel Therapeutics, Inc.
August 24, 2023
From
Brodsky & Smith LLC
Via
GlobeNewswire
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: ElectraMeccanica (Nasdaq - SOLO), Computer Task Group, Incorporated (Nasdaq - CTG), Decibel Therapeutics, Inc. (Nasdaq - DBTX)
August 15, 2023
From
Brodsky & Smith LLC
Via
GlobeNewswire
DECIBEL THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Decibel Therapeutics, Inc. - DBTX
August 12, 2023
From
Kahn Swick & Foti, LLC
Via
Business Wire
Benzinga's 'Stock Whisper' Index: 5 Stocks Investors Are Secretly Monitoring But Not Talking About Yet
August 11, 2023
Investors are on the hunt for undervalued, underfollowed and emerging stocks, and retail traders have countless methods at their disposal to uncover new information. For some, this may be...
Via
Benzinga
Decibel Therapeutics Reports Second Quarter 2023 Financial Results and Corporate Update
August 11, 2023
From
Decibel Therapeutics, Inc.
Via
GlobeNewswire
Benzinga's Top Ratings Upgrades, Downgrades For August 10, 2023
August 10, 2023
Via
Benzinga
Global Payments To Rally Around 17%? Here Are 10 Other Analyst Forecasts For Thursday
August 10, 2023
Keybanc cut the price target for i3 Verticals, Inc. (NASDAQ: IIIV) from $28 to $26. Keybanc analyst Josh Beck maintained an Overweight rating. i3 Verticals shares fell 2.9% to close at $22.76 on...
Via
Benzinga
Dow Edges Higher; Tigo Energy Shares Plunge
August 09, 2023
U.S. stocks pared some losses toward the end of trading, with the Dow Jones turning higher on Wednesday. The Dow traded up 0.05% to 35,332.35 while the NASDAQ fell 0.46% to 13,820.37. The S&P 500, also...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Why Cutera Shares Are Trading Lower By Around 22%? Here Are Other Stocks Moving In Wednesday's Session
August 09, 2023
Gainers Tango Therapeutics, Inc. (NASDAQ: TNGX) climbed 85.2% to $7.09 after gaining 11% on Tuesday. Tango Therapeutics recently posted a narrower quarterly loss.
Via
Benzinga
Akamai Technologies, Array Technologies Music, HNI, PENN Entertainment And Other Big Stocks Moving Higher On Wednesday
August 09, 2023
U.S. stocks traded lower, with the Nasdaq Composite falling around 100 points on Wednesday. Here are some big stocks recording gains in today’s session.
Via
Benzinga
Topics
Stocks
Exposures
US Equities
12 Health Care Stocks Moving In Wednesday's Intraday Session
August 09, 2023
Via
Benzinga
Nasdaq Down 1%; Decibel Therapeutics Shares Spike Higher
August 09, 2023
U.S. stocks were lower midway through trading, with the Nasdaq Composite falling around 1% on Wednesday. The Dow traded down 0.52% to 35,130.45 while the NASDAQ fell 1.03% to 13,741.71. The S&P 500,...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Health Care Company Regeneron Pharmaceuticals Announces Acquisition of Decibel Therapeutics
August 09, 2023
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For August 9, 2023
August 09, 2023
Via
Benzinga
Why Is Tango Therapeutics (TNGX) Stock Up 117% Today?
August 09, 2023
Tango Therapeutics (TNGX) stock is soaring higher on Wednesday after getting a couple of updates from analysts covering the shares.
Via
InvestorPlace
YELL Stock Alert: Yellow Receives Nasdaq Delisting Notice
August 09, 2023
Yellow (YELL) stock is falling on Wednesday after the struggling U.S. trucking company received a Nasdaq delisting notice!
Via
InvestorPlace
DBTX Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Decibel Therapeutics, Inc. Is Fair to Shareholders
August 09, 2023
From
Halper Sadeh LLC
Via
Business Wire
US Stocks Edge Lower; Charles River Earnings Top Estimates
August 09, 2023
U.S. stocks were mostly lower this morning, with the Nasdaq Composite falling more than 50 points on Wednesday. Following the market opening Wednesday, the Dow traded down 0.03% to 35,303.64 while the...
Via
Benzinga
Decibel Therapeutics (DBTX) Stock Skyrockets 71% on Regeneron Deal
August 09, 2023
Decibel Therapeutics (DBTX) stock is soaring higher on Wednesday after signing a deal with Regeneron Pharmaceuticals (REGN).
Via
InvestorPlace
Decibel Therapeutics Stock Soars on Acquisition Deal - The Details
August 09, 2023
Regeneron Pharmaceuticals Inc (NASDAQ: REGN) has agreed to acquire Decibel Therapeutics Inc (NASDAQ: DBTX) at $4.00 per share with an additional contingent value right of up to $3.50 per share in cash...
Via
Benzinga
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Computer Task Group, Incorporated (Nasdaq - CTG), Decibel Therapeutics, Inc. (Nasdaq - DBTX)
August 09, 2023
From
Brodsky & Smith LLC
Via
GlobeNewswire
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
August 09, 2023
Via
Benzinga
Regeneron to Acquire Decibel Therapeutics, Strengthening Gene Therapy and Hearing Loss Programs
August 09, 2023
From
Regeneron Pharmaceuticals, Inc.; Decibel Therapeutics, Inc.
Via
GlobeNewswire
Decibel Therapeutics to Participate in the Upcoming Jefferies Healthcare Conference
June 02, 2023
From
Decibel Therapeutics, Inc.
Via
GlobeNewswire
Decibel Therapeutics to Present DB-020 Phase 1b Clinical Trial Data at the American Society of Clinical Oncology (ASCO) 2023 Annual Meeting
June 01, 2023
Data from interim analysis support DB-020 as a potential therapy to protect patients against irreversible hearing loss associated with cisplatin chemotherapy
From
Decibel Therapeutics, Inc.
Via
GlobeNewswire
Decibel Therapeutics to Participate in the Upcoming Barclays 2023 Gene Editing and Gene Therapy Summit
May 17, 2023
From
Decibel Therapeutics, Inc.
Via
GlobeNewswire
Decibel Therapeutics Reports First Quarter 2023 Financial Results and Corporate Update
May 15, 2023
From
Decibel Therapeutics, Inc.
Via
GlobeNewswire
Decibel Therapeutics Announces Approval of Clinical Trial Application by the Spanish Agency of Medicines and Medical Devices (AEMPS) to Initiate Clinical Development of Lead Gene Therapy Candidate DB-OTO
May 12, 2023
CTA authorization provides approval for the Company to expand its planned CHORD™ Phase 1/2 clinical trial of DB-OTO to patients in Spain aged two years and younger
From
Decibel Therapeutics, Inc.
Via
GlobeNewswire
< Previous
1
2
3
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.